DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trisenox (Arsenic Trioxide) - Gamma-Glutamyltransferase Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Gamma-Glutamyltransferase Increased (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trisenox (Arsenic Trioxide) where reactions include gamma-glutamyltransferase increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Trisenox side effects in 64 year old female

Reported by a physician from United Kingdom on 2011-10-18

Patient: 64 year old female

Reactions: Gamma-Glutamyltransferase Increased

Drug(s) suspected as cause:
Atracurium Besylate
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-15
    End date: 2011-07-18

Gemtuzumab Ozogamicin
    Dosage: 6 mg unit dose at unknown frequency
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-15
    End date: 2011-07-29

Gemtuzumab Ozogamicin
    Indication: Myelodysplastic Syndrome

Trisenox
    Indication: Myelodysplastic Syndrome

Atracurium Besylate
    Dosage: unk
    Indication: Myelodysplastic Syndrome
    Start date: 2011-08-04

Trisenox
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-15
    End date: 2011-07-29



Possible Trisenox side effects in female

Reported by a physician from United Kingdom on 2011-10-06

Patient: female

Reactions: Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased

Drug(s) suspected as cause:
Atracurium Besylate
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-15
    End date: 2011-07-18

Atracurium Besylate
    Dosage: 50% of original dosage
    Start date: 2011-08-04

Mylotarg
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-18

Trisenox
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-18
    End date: 2011-07-29



Possible Trisenox side effects in 64 year old female

Reported by a physician from United Kingdom on 2011-10-06

Patient: 64 year old female

Reactions: Gamma-Glutamyltransferase Increased

Drug(s) suspected as cause:
Gemtuzumab Ozogamicin
    Dosage: 6 mg unit dose at unknown frequency
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-15
    End date: 2011-07-29

Atracurium Besylate
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-15
    End date: 2011-07-18

Atracurium Besylate
    Dosage: unk
    Indication: Myelodysplastic Syndrome
    Start date: 2011-08-04

Trisenox
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-15
    End date: 2011-07-29

Trisenox
    Indication: Myelodysplastic Syndrome

Gemtuzumab Ozogamicin
    Indication: Myelodysplastic Syndrome

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017